Serum Retinol-Binding Protein 4 as a Marker for Cardiovascular Disease in Women

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Alkharfy, Khalid M ^a,b   Al Daghri, Nasser M ^b   Vanhoutte, Paul M ^c   Krishnaswamy, Soundararajan ^b   Xu, Aimin ^c  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FATTY ACID BINDING PROTEIN 4; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; RETINOL BINDING PROTEIN 4; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC OBESITY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; IMMUNOASSAY; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ACUTE-PHASE PROTEINS; ADULT; AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; DIABETES MELLITUS; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; LIPOCALINS; MALE; MIDDLE AGED; OBESITY; PRINCIPAL COMPONENT ANALYSIS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RETINOL-BINDING PROTEINS, PLASMA; RISK FACTORS; SEX FACTORS; TRIGLYCERIDES;

EID: 84868316900     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048612     Document Type: Article

References (38)

1. Libby P, (2006) Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr 83: 456S-460S.
2. Ouwens DM, Sell H, Greulich S, Eckel J, (2010) The role of epicardial and perivascular adipose tissue in the pathophysiology of cardiovascular disease. J Cell Mol Med 14: 2223-2234.
3. Xu A, Wang Y, Xu JY, Stejskal D, Tam S, et al. (2006) Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem 52: 405-413.
4. Kazemi MR, McDonald CM, Shigenaga JK, Grunfeld C, Feingold KR, (2005) Adipocyte fatty acid-binding protein expression and lipid accumulation are increased during activation of murine macrophages by toll-like receptor agonists. Arterioscler Thromb Vasc Biol 25: 1220-1224.
5. Hsu BG, Chen YC, Lee RP, Lee CC, Lee CJ, et al. (2010) Fasting serum level of fatty-acid-binding protein 4 positively correlates with metabolic syndrome in patients with coronary artery disease. Circ J 74: 327-331.
6. Mohlig M, Weickert MO, Ghadamgadai E, Machlitt A, Pfuller B, et al. (2007) Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women. Eur J Endocrinol 157: 195-200.
7. Stejskal D, Karpisek M, (2006) Adipocyte fatty acid binding protein in a Caucasian population: a new marker of metabolic syndrome? Eur J Clin Invest 36: 621-625.
8. Xu A, Tso AW, Cheung BM, Wang Y, Wat NM, et al. (2007) Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study. Circulation 115: 1537-1543.
9. Tso AW, Xu A, Sham PC, Wat NM, Wang Y, et al. (2007) Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort. Diabetes Care 30: 2667-2672.
10. Xiao Y, Yao L, Li X, Zhong H, Chen XY, et al. (2010) [Relationship of adipocyte fatty acid-binding protein to adiponectin ratio with femoral intima-media thickness and endothelium-dependent vasodilation in patients with newly-diagnosed type 2 diabetes mellitus]. Zhonghua Yi Xue Za Zhi 90: 231-235.
11. Miyoshi T, Onoue G, Hirohata A, Hirohata S, Usui S, et al. (2010) Serum adipocyte fatty acid-binding protein is independently associated with coronary atherosclerotic burden measured by intravascular ultrasound. Atherosclerosis 211: 164-169.
12. Rhee EJ, Lee WY, Park CY, Oh KW, Kim BJ, et al. (2009) The association of serum adipocyte fatty acid-binding protein with coronary artery disease in Korean adults. Eur J Endocrinol 160: 165-172.
13. Tso AW, Lam TK, Xu A, Yiu KH, Tse HF, et al. (2010) Serum adipocyte fatty acid-binding protein associated with ischemic stroke and early death. Neurology 76: 1968-1975.
14. Yeung DC, Xu A, Tso AW, Chow WS, Wat NM, et al. (2009) Circulating levels of adipocyte and epidermal fatty acid-binding proteins in relation to nephropathy staging and macrovascular complications in type 2 diabetic patients. Diabetes Care 32: 132-134.
15. Wang Y, Lam KS, Kraegen EW, Sweeney G, Zhang J, et al. (2007) Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin Chem 53: 34-41.
16. Yan QW, Yang Q, Mody N, Graham TE, Hsu CH, et al. (2007) The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes 56: 2533-2540.
17. Catalan V, Gomez-Ambrosi J, Rodriguez A, Ramirez B, Silva C, et al. (2009) Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans. J Mol Med (Berl) 87: 803-813.
18. Zhang J, Wu Y, Zhang Y, Leroith D, Bernlohr DA, et al. (2008) The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages. Mol Endocrinol 22: 1416-1426.
19. Friebe D, Neef M, Erbs S, Dittrich K, Kratzsch J, et al. (2011) Retinol binding protein 4 (RBP4) is primarily associated with adipose tissue mass in children. Int J Pediatr Obes 6: e345-352.
20. Broch M, Ramirez R, Auguet MT, Alcaide MJ, Aguilar C, et al. (2010) Macrophages are novel sites of expression and regulation of retinol binding protein-4 (RBP4). Physiol Res 59: 299-303.
21. Oberbach A, Bluher M, Wirth H, Till H, Kovacs P, et al. (2011) Combined proteomic and metabolomic profiling of serum reveals association of the complement system with obesity and identifies novel markers of body fat mass changes. J Proteome Res 10: 4769-4788.
22. Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, et al. (2006) Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 354: 2552-2563.
23. Cabre A, Lazaro I, Girona J, Manzanares J, Marimon F, et al. (2007) Retinol-binding protein 4 as a plasma biomarker of renal dysfunction and cardiovascular disease in type 2 diabetes. J Intern Med 262: 496-503.
24. Ingelsson E, Sundstrom J, Melhus H, Michaelsson K, Berne C, et al. (2009) Circulating retinol-binding protein 4, cardiovascular risk factors and prevalent cardiovascular disease in elderly. Atherosclerosis 206: 239-244.
25. Johnson R, McNutt P, MacMahon S, Robson R, (1997) Use of the Friedewald formula to estimate LDL-cholesterol in patients with chronic renal failure on dialysis. Clin Chem 43: 2183-2184.
26. Xiang Y, Zhou P, Li X, Huang G, Liu Z, et al. (2011) Heterogeneity of altered cytokine levels across the clinical spectrum of diabetes in China. Diabetes Care 34: 1639-1641.
27. Everett CJ, Mainous AG 3rd, Koopman RJ, Diaz VA (2005) Predicting coronary heart disease risk using multiple lipid measures. Am J Cardiol 95: 986-988.
28. Hillier TA, Rousseau A, Lange C, Lepinay P, Cailleau M, et al. (2006) Practical way to assess metabolic syndrome using a continuous score obtained from principal components analysis. Diabetologia 49: 1528-1535.
29. Hsu FC, Kritchevsky SB, Liu Y, Kanaya A, Newman AB, et al. (2009) Association between inflammatory components and physical function in the health, aging, and body composition study: a principal component analysis approach. J Gerontol A Biol Sci Med Sci 64: 581-589.
30. Wu J, Shi YH, Niu DM, Li HQ, Zhang CN, et al. (2012) Association among retinol-binding protein 4, small dense LDL cholesterol and oxidized LDL levels in dyslipidemia subjects. Clin Biochem 45: 619-622.
31. Kos K, Wong S, Tan BK, Kerrigan D, Randeva HS, et al. (2011) Human RBP4 adipose tissue expression is gender specific and influenced by leptin. Clin Endocrinol (Oxf) 74: 197-205.
32. Arbustini E, Morbini P, Bello BD, Prati F, Specchia G, (1999) From plaque biology to clinical setting. Am Heart J 138: S55-60.
33. Hochman JS, Tamis JE, Thompson TD, Weaver WD, White HD, et al. (1999) Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators. N Engl J Med 341: 226-232.
34. Villablanca AC, Jayachandran M, Banka C, (2010) Atherosclerosis and sex hormones: current concepts. Clin Sci (Lond) 119: 493-513.
35. Huang G, Wang D, Khan UI, Zeb I, Manson JE, et al. (2012) Associations between retinol-binding protein 4 and cardiometabolic risk factors and subclinical atherosclerosis in recently postmenopausal women: Cross-sectional analyses from the KEEPS Study. Cardiovasc Diabetol 11: 52.
36. Daniels LB, Barrett-Connor E, Clopton P, Laughlin GA, Ix JH, et al. (2012) Plasma neutrophil gelatinase-associated lipocalin is independently associated with cardiovascular disease and mortality in community-dwelling older adults: The Rancho Bernardo Study. J Am Coll Cardiol 59: 1101-1109.
37. Lee JW, Im JA, Lee HR, Shim JY, Youn BS, et al. (2007) Visceral adiposity is associated with serum retinol binding protein-4 levels in healthy women. Obesity (Silver Spring) 15: 2225-2232.
38. Kloting N, Graham TE, Berndt J, Kralisch S, Kovacs P, et al. (2007) Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Cell Metab 6: 79-87.